✦ LIBER ✦

Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects

✍ Scribed by Burt Angrist; June Corwin; Barbara Bartlik; Thomas Cooper

Book ID: 118317513
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 962 KB
Volume: 22
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(87)90070-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical pharmacokinetics of buflome

The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration

✍ U. Gundert-Remy; E. Weber; G. Lam; W. L. Chiou; W. Mann; G. H. Aynilian 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 612 KB

Pharmacokinetics and Oral Bioavailabilit

Pharmacokinetics and Oral Bioavailability of Scopolamine in Normal Subjects

✍ Lakshmi Putcha; Nitza M. Cintrón; James Tsui; James M. Vanderploeg; William G. K 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 768 KB

Pharmacokinetics of intravenous and oral

Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.

✍ CA James; TG Mant; HJ Rogers 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Metabolic and renal effects of an oral l

Metabolic and renal effects of an oral load of D(−) 3hydroxybutyrate in normal subjects

📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 106 KB

ACUTE HAEMODYNAMIC AND HORMONAL EFFECTS

ACUTE HAEMODYNAMIC AND HORMONAL EFFECTS OF ORAL DOXAZOSIN IN NORMAL SUBJECTS

✍ Judith A. Whitworth; Jill Butty; Deanna Gordon 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Lack of Amphetamine-Like Effects After A

Lack of Amphetamine-Like Effects After Administration of Mefenorex in Normal Young Subjects

✍ ALAIN PATAT; MICKÄEL CERCLE; SUZANNE TROCHERIE; GUYLAINE PEYTAVIN; CHRISTOPHE PO 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1014 KB

Mefenorex is an indirect sympathomimetic amine which acts as an anorectic drug and is used in combination with low diet to treat excess weight. The central nervous system (CNS) effects of mefenorex were assessed in a randomized, double-blind, three-way cross-over, placebocontrolled study involving n